News and Press Releases
Treovir Announces Opening of G207 Phase 2 Clinical Trial in Children with Recurrent Brain Tumors
4 December 2024 -- Alabama, US -- Treovir, Inc. announced today the opening of a Phase 2 trial testing G207, an oncolytic HSV immunotherapy, in pediatric brain tumor patients. G207...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other
Posted: December 4, 2024
SnapSlide™ Wins IoPP People’s Choice Award at PACK EXPO Chicago 2024
Patented solution awarded for aiding consumers with physical limitations, while reducing plastic usage compared to conventional caps. 3 December 2024 – Scranton, PA, US – SnapSlide, LLC, a packaging innovations...
Category: Manufacturing and Packing
Posted: December 4, 2024
Epsilogen announces initiation of Phase Ib trial of MOv18 IgE
Proof-of-concept study to evaluate the safety, tolerability and efficacy of MOv18 IgE in patients with platinum-resistant ovarian cancer 3 December 2024 -- London, UK -- Epsilogen, the global leader in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: December 3, 2024
Novo Nordisk to present new data from sickle cell disease and haemophilia trials at the 66th American Society of Hematology (ASH) annual meeting
HIBISCUS phase 2 data evaluating the safety profile and efficacy of etavopivat in adult and adolescent patients with sickle cell disease FRONTIER4 interim phase 3 results evaluating safety profile and...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: December 3, 2024
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer
First regulatory approval for fruquintinib combination therapy with an immune checkpoint inhibitor 3 December 2024 -- Hong Kong, Shanghai and New Jersey, US — HUTCHMED (China) and Innovent Biologics, Inc...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: December 3, 2024
BIOCHINA 2025: China’s Largest Bio Convention to Host Over 3,000 Biotech Companies
28 November 2024 –Suzhou, China – BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around...
Category: Biotechnology
Posted: November 28, 2024
BIOCHINA 2025 Announces Esteemed Expert Committee to Guide International Convention in Suzhou
28 November 2024 –Shanghai, China – BIOCHINA, Asia’s leading platform for biotechnology and pharmaceutical innovation, proudly announces the appointment of an Expert Committee for the upcoming BIOCHINA 2025 International Convention....
Category: Biotechnology
Posted: November 28, 2024
UK’s MHRA grants Promising Innovative Medicine designation to argenx’ investigational therapy, subcutaneous efgartigimod alfa for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)
28 November 2024 -- Gerrards Cross, UK -- argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, confirmed today that its investigational...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 28, 2024
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG
Biotech Showcase™ marking 17 years of innovation and opportunity
November 27 2024 – San Francisco, CA – Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech...
Category: Other
Posted: November 27, 2024
ACG Launches ADAPT X at CPhI & PMEC India 2024
Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions 26 November 2024 – ACG Engineering, a division of ACG, a leading supplier of integrated manufacturing...
Category: Manufacturing and Packing
Posted: November 27, 2024
Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives
Funding to support further development of lead programme for a novel therapeutic targeting Gram-negative bacteria including Multi-Drug-Resistant strains Optimisation will also support application of the Alphamer® platform across other therapeutic...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: November 25, 2024
Bormioli Pharma Invents: the open and collaborative innovation platform for the pharmaceutical packaging of the future
A project aimed at envisioning and designing cutting-edge solutions that meet the real needs of patients while actively shaping the future of the pharmaceutical industry. 22 November 2024 – Parma,...
Category: Manufacturing and Packing
Posted: November 22, 2024
Sustainable growth: Syntegon achieves SBTi validation
Sustainability confirmed as key element of Syntegon’s corporate strategy Syntegon aims to reduce Scope 3 CO2 emissions by 25 percent, as well as Scope 1 and 2 emissions by 48.3...
Category:
Posted: November 21, 2024
‘Perfect for purpose’ has to be the standard for pharma industry, says leading hygiene expert
Teknomek reports 56% increase in bespoke orders 20 November 2024 – Hygienic furniture and equipment specialist Teknomek, has today reported a 56% increase in bespoke orders, demonstrating that the pharmaceutical...
Category: Manufacturing and Packing
Posted: November 21, 2024
Samsung Biologics signs manufacturing deal with European pharmaceutical company
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics’ cumulative contract value for 2024 surpasses USD 4 billion with latest deals 20...
Category:
Posted: November 20, 2024
